Is ZBH stock a buy or a sell according to analysts?

Of the 42 analyst ratings on Zimmer Biomet Holdings, Inc., 40% are Buy or Strong Buy, 22 are Hold, and 3 are Sell. The overall consensus rating is Hold. Analyst ratings are opinions, not investment advice.

What is the analyst price target for ZBH?

The average analyst price target for Zimmer Biomet Holdings, Inc. is $103.11. Individual targets range from $93.00 to $120.00.

When is Zimmer Biomet Holdings, Inc.'s next earnings date?

Zimmer Biomet Holdings, Inc. is scheduled to report earnings on November 4, 2026. Analysts expect earnings of $1.88 per share.

Does Zimmer Biomet Holdings, Inc. pay a dividend?

Yes — Zimmer Biomet Holdings, Inc. has paid $0.96 per share in dividends over the trailing twelve months.

How volatile is ZBH stock?

ZBH has a beta of 0.48, meaning it has historically been less volatile than the broader market.

What sector is Zimmer Biomet Holdings, Inc. in?

Zimmer Biomet Holdings, Inc. operates in the Healthcare sector, the Medical - Devices industry, and its stock trades on NYSE.

Back to Markets

Open ZBH on Vela

Zimmer Biomet Holdings, Inc.

ZBH

0.00

USD

+0.00+0.00%

Overview Financials News Trades Technicals Forecast Transcripts

Zimmer Biomet Holdings, Inc. at a glance

Open ZBH on Vela

Zimmer Biomet Holdings, Inc. (ZBH) is a Healthcare company in the Medical - Devices industry, headquartered in Warsaw, IN, with about 17,000 employees. Its shares trade on NYSE, and its IPO date is July 25, 2001. With a market capitalization of $18.8 billion, ZBH is a large-cap stock.

It trades an average of 2.2 million shares a day.

In its latest reported quarter (results released August 5, 2026), Zimmer Biomet Holdings, Inc. posted revenue of $2.2 billion and earnings of $2.07 per share, against estimates of $2.1 billion and $2.01.

Figures as of October 26, 2026, from market data providers. Descriptive only, not financial advice.

ZBH: Frequently asked questions

As of October 26, 2026, Zimmer Biomet Holdings, Inc. has a market capitalization of $18.8 billion, making it a large-cap company in the Healthcare sector.

Figures update throughout the day from market data providers. Nothing on this page is financial advice.